N. Scott Fine - Oct 20, 2023 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Executive Officer, Director
Signature
/s/ N. Scott Fine
Stock symbol
CYTH
Transactions as of
Oct 20, 2023
Transactions value $
$175,150
Form type
4
Date filed
10/23/2023, 06:05 AM
Previous filing
Apr 24, 2023
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTH Common Stock Exercise of in-the-money or at-the-money derivative security $213K +299K +67.37% $0.71 744K Oct 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Warrant to Purchase Common Stock Exercise of in-the-money or at-the-money derivative security -$37.4K -299K -100% $0.13 0 Oct 20, 2023 Common Stock 299K $0.71 Direct
transaction CYTH Warrant to Purchase Common Stock Purchase +329K 329K Oct 20, 2023 Common Stock 329K $0.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person exercised vested Warrants (the "Original Warrants") to purchase 299,402 shares of the Issuer's common stock pursuant to a Securities Purchase Agreement dated October 20, 2023 ("Closing Date"). The Reporting Person exercised his Original Warrant in full on or prior to the Closing Date in consideration of the receipt of new warrants with an exercise price equal to $0.95 per share, to purchase 110% of the shares of the Issuer's common stock covered under the Original Warrants.